CIK 0001826892 · Non-accelerated filer<br>Smaller reporting company
BioAtla, Inc.
Sign in to watch- Ticker
- BCAB
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851922320
- Phone
- 858-558-0708
- Business address
- 11085 TORREYANA ROAD, SAN DIEGO, CA, 92121
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Exit or restructuring costs
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Executive or director change
- 4 Grant or award See Remarks acquired 85,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 431,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 175,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 30,911 shares (to pay taxes)
Page 5 of 26 · 509 filings